UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
Read moreWed, 01st Apr 2020 13:57
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
Read more(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.
Read moreUK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair
Read moreUK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair
Read moreREPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out
Read moreValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out
Read more(Sharecast News) - Clinical-stage biotechnology company ValiRx announced a conditional fundraise through the conditional issue of 18,069,467 new ordinary shares on Monday, to raise ?1.17m.
Read moreUK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO
Read more(Sharecast News) - Clinical-stage biotechnology company ValiRx has signed an agreement with an unnamed global Japanese pharmaceutical company to evaluate its therapeutic, VAL301, in order to contemplate a potential future license for its use in the treatment of endometriosis.
Read moreValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm
Read moreUK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking
Read moreValiRx Confirms JV Talks For Non-Core Intellectual Property
Read moreUK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more